• Industry: Drug Discovery/Drug Development
  • Location: Newton, MA
  • Summary: Abcuro is developing first-in-class immunotherapies for autoimmune diseases and cancer through precise elimination or modulation of cytotoxic T and NK cells via KLRG1

 

Aramis Biosciences
Avilar Therapeutics, Inc.
Menu